Last checked at 7 May 2024 09:51
LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades866
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,771.00
Bid:
1,770.50
Ask:
1,771.50
Change:
10.00 (0.57%)
Spread:
1.00 (0.056%)
Open:
1,770.00
High:
1,772.00
Low:
1,766.00
Prev. Close:
1,761.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.London pre-open: stocks set to plunge as China off the rails
Fri, 21st Aug 2015 07:20
(ShareCast News) - City sources predict the FTSE 100 will open 142 points lower than Thursday's close of 6,367.89."European equities are set to plunge on the open as China goes off the rails," London Capital Group night dealer Jonathan Sudaria said.Sudaria said bulls were already slowed by a barrage of negative cues including weak economic data and political instability in Greece after Alex Tsipras quit."As the bulls lay bleeding out at the bottom of yesterday session, overnight, China has delivered the mortal blow," Sudaria said.August manufacturing and services PMI data from France and Germany was expected on Friday, while CMC Markets said UK Public sector borrowing for July is expected to see a repayment of £2.8bn, and improvement on the £8.6bn deficit in June.Stocks to watchSpire Healthcare said it swung to a profit after tax in the first half as revenue grew across the business, but the private healthcare company cut its revenue guidance for the year, citing weaker demand from the NHS. Spire posted a profit of £30.8m compared with a loss of £7.8m in the same period last year, as revenue grew 7.8% to £449.8m.GlaxoSmithKline has sold all the rights to its ofatumumab drug to Novartis for £1.03bn, extending a previous disposal agreement. GSK previously agreed to divest the drug's oncology indications and has now agreed to include its rights in ofatumumab for auto-immune indications, including multiple sclerosis.In the pressGreece is to hold a snap general election, likely to be on 20 September, just weeks after securing a new €86bn bailout deal with it international creditors. Fresh elections called by prime minister Alexis Tsipras on the very first day of the bailout programme, will plunge Greece back into short-term political uncertainty. - Financial TimesBritain and Iran will take an important step towards r-establishing full diplomatic relatons this weekend when Philip Hammond reopens the British embassy in Tehran after a four-year gap. Hammond will travel to the Iranian capital to reopen the mission which was close in 2011 after a mob attack. - Financial TimesPressure is building on Saudi Arabia from members within the Organisation of the Petroleum Exporting Countries (Opec) to agree to an emergency meeting to arrest plummeting oil prices. The Telegraph understands that Opec's secretary general, Abdulla Salem el-Badri, has spoken to Saudi officials on behalf of members within the group who are coming under extreme economic pressure from oil prices dropping towards levels of $40 per barrel.
More News
2 May 2024 19:57
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more2 May 2024 09:48
LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more1 May 2024 19:39
Bird flu testing shows more dairy products are safe, US FDA says
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.
Read more1 May 2024 17:31
UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh
FTSE 100 down 0.3%, FTSE 250 off 0.2%
*Read more1 May 2024 16:56
LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.
Read more1 May 2024 16:42
London close: Stocks fall ahead of US Fed decision
(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.
Read more1 May 2024 11:55
LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage
(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.
Read more1 May 2024 10:54
GSK raises profit outlook on strong vaccine, HIV drug sales
FY profit forecast raised to 8-10%
*Read more1 May 2024 08:57
LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed
(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.
Read more1 May 2024 08:50
TOP NEWS: GSK expects momentum to continue after strong first quarter
(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.
Read more1 May 2024 07:46
LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast
(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.
Read more1 May 2024 07:36
GSK lifts annual guidance on strong virus treatment sales
(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
Read more30 Apr 2024 23:46
First trial over Zantac cancer claims set to begin in Chicago
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Read more30 Apr 2024 22:39
First trial over Zantac cancer claims set to begin in Chicago
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Read more